Phloretin-induced cytoprotective effects on mammalian cells: A mechanistic view and future directions

BioFactors

Volumn 42, Issue 1, 2016, Pages 13-40

  De Oliveira, Marcos Roberto ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

Anti inflammatory; Anti tumor; Antioxidant; Phloretin; Phloridzin; Toxicity

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; GLUCOSE TRANSPORTER 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PHLORETIN; PHLORIZIN; POLYPHENOL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; FLAVONOID;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CELL; CELL PROTECTION; DRUG BIOAVAILABILITY; EXPERIMENTAL ALLERGY; EXPERIMENTAL INFLAMMATION; EXPERIMENTAL MODEL; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; LIVER CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; ANIMAL; ANIMAL MODEL; CHEMISTRY; DRUG EFFECTS; MALUS; MOUSE; RAT;

ANIMALS; ANTIOXIDANTS; CYTOPROTECTION; FLAVONOIDS; HUMANS; MALUS; MICE; MODELS, ANIMAL; PHLORETIN; PHLORHIZIN; RATS;

EID: 84959323140     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1256     Document Type: Article

References (215)

1. Lee, K. W., Kim, Y. J., Kim, D. O., Lee, H. J., and Lee, C. Y. (2003) Major phenolics in apple and their contribution to the total antioxidant capacity. J. Agric. Food Chem. 51, 6516-6520. doi: 10.1021/jf034475w.
2. Tsao, R., Yang, R., Young, J. C., and Zhu, H. (2003) Polyphenolic profiles in eight apple cultivars using high-performance liquid chromatography (HPLC). J. Agric. Food Chem. 51, 6347-6353. doi: 10.1021/jf0346298.
3. Boyer, J. and Liu, R. H. (2004) Apple phytochemicals and their health benefits. Nutr. J. 3, 5. doi: 10.1186/1475-2891-3-5.
4. Calliste, C. A., Le Bail, J. C., Trouillas, P., Pouget, C., Habrioux, G., et al. (2001) Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer. Res. 21, 3949-3956.
5. de Beer, D., Schulze, A. E., Joubert, E., de Villiers, A., Malherbe, C. J., et al. (2012) Food ingredient extracts of Cyclopia subternata (Honeybush): variation in phenolic composition and antioxidant capacity. Molecules 17, 14602-14624. doi: 10.3390/molecules171214602
6. Sun, Y., Li, W., and Liu, Z. (2015) Preparative isolation, quantification and antioxidant activity of dihydrochalcones from Sweet Tea (Lithocarpus polystachyus Rehd.). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1002, 372-378. doi: 10.1016/j.jchromb.2015.08.045
7. Hanen, F., Riadh, K., Samia, O., Sylvain, G., Christian, M., et al. (2009) Interspecific variability of antioxidant activities and phenolic composition in Mesembryanthemum genus. Food Chem. Toxicol. 47, 2308-2313. doi: 10.1016/j.fct.2009.06.025
8. Yao, G. M., Ding, Y., Zuo, J. P., Wang, H. B., Wang, Y. B., et al. (2005) Dihydrochalcones from the leaves of Pieris japonica. J. Nat. Prod. 68, 392-396. doi: 10.1021/np049698a
9. Mancini, S. D. and Edwards, J. M. (1979) Cytotoxic principles from the sap of Kalmia latifolia. J. Nat. Prod. 42, 483-488.
10. An, R. B., Park, E. J., Jeong, G. S., Sohn, D. H., and Kim, Y. C. (2007) Cytoprotective constituent of Hoveniae lignum on both Hep G2 cells and rat primary hepatocytes. Arch. Pharmacol. Res. 30, 674-677.
11. Cuendet, M., Potterat, O., Salvi, A., Testa, B., and Hostettmann, K. (2000) A stilbene and dihydrochalcones with radical scavenging activities from Loiseleuria procumbens. Phytochemistry 54, 871-874.
12. Crespy, V., Aprikian, O., Morand, C., Besson, C., Manach, C., et al. (2001) Bioavailability of phloretin and phloridzin in rats. J. Nutr. 131, 3227-3230.
13. Liaudanskas, M., Viškelis, P., Raudonis, R., Kviklys, D., Uselis, N., et al. (2014) Phenolic composition and antioxidant activity of Malus domestica leaves. Sci. World J. 2014, 306217. doi: 10.1155/2014/306217.
14. DuPont, M. S., Bennett, R. N., Mellon, F. A., and Williamson, G. (2002) Polyphenols from alcoholic apple cider are absorbed, metabolized and excreted by humans. J. Nutr. 132, 172-175.
15. Mullen, W., Borges, G., Lean, M. E., Roberts, S. A., and Crozier, A. (2010) Identification of metabolites in human plasma and urine after consumption of a polyphenol-rich juice drink. J. Agric. Food Chem. 58, 2586-2595. doi: 10.1021/jf904096v.
16. Kahle, K., Kempf, M., Schreier, P., Scheppach, W., Schrenk, D., et al. (2011) Intestinal transit and systemic metabolism of apple polyphenols. Eur. J. Nutr. 50, 507-522. doi: 10.1007/s00394-010-0157-0.
17. Kahle, K., Huemmer, W., Kempf, M., Scheppach, W., Erk, T., et al. (2007) Polyphenols are intensively metabolized in the human gastrointestinal tract after apple juice consumption. J. Agric. Food Chem. 55, 10605-10614. doi: 10.1021/jf071942r.
18. Marks, S. C., Mullen, W., Borges, G., and Crozier, A. (2009) Absorption, metabolism, and excretion of cider dihydrochalcones in healthy humans and subjects with an ileostomy. J. Agric. Food Chem. 57, 2009-2015. doi: 10.1021/jf802757x.
19. Stracke, B. A., Rüfer, C. E., Bub, A., Seifert, S., Weibel, F. P., et al. (2010) No effect of the farming system (organic/conventional) on the bioavailability of apple (Malus domestica Bork., cultivar Golden Delicious) polyphenols in healthy men: a comparative study. Eur. J. Nutr. 49, 301-310. doi: 10.1007/s00394-009-0088-9.
20. Choi, B. M., Chen, X. Y., Gao, S. S., Zhu, R., and Kim, B. R. (2011) Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells. Pharmacol. Rep. 63, 708-716.
21. Zhu, Q., Zhang, N. Q., Lau, C. F., Chao, J., Sun, Z., et al. (2012) In vitro attenuation of acrolein-induced toxicity by phloretin, a phenolic compound from apple. Food Chem. 135, 1762-1768. doi: 10.1016/j.foodchem.2012.06.053.
22. Witz, G. (1989) Biological interactions of alpha, beta-unsaturated aldehydes. Free Radic. Biol. Med. 7, 333-349.
23. Ullen, A., Fauler, G., Bernhart, E., Nusshold, C., Reicher, H., et al. (2012) Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro. Free Radic. Biol. Med. 53, 1770-1781. doi: 10.1016/j.freeradbiomed.2012.08.575.
24. Chung, M. J., Sohng, J. K., Choi, D. J., and Park, Y. I. (2013) Inhibitory effect of phloretin and biochanin A on IgE-mediated allergic responses in rat basophilic leukemia RBL-2H3 cells. Life Sci. 93, 401-408. doi: 10.1016/j.lfs.2013.07.019.
25. Liu, Y., Zhang, L., and Liang, J. (2015) Activation of the Nrf2 defense pathway contributes to neuroprotective effects of phloretin on oxidative stress injury after cerebral ischemia/reperfusion in rats. J. Neurol. Sci. 351, 88-92. doi: 10.1016/j.jns.2015.02.045.
26. Ghumatkar, P. J., Patil, S. P., Jain, P. D., Tambe, R. M., and Sathaye, S. (2015) Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice. Pharmacol. Biochem. Behav. 135, 182-191. doi: 10.1016/j.pbb.2015.06.005.
27. Yang, Y. C., Lii, C. K., Lin, A. H., Yeh, Y. W., Yao, H. T., et al. (2011) Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress. Free Radic. Biol. Med. 51, 2073-2081. doi: 10.1016/j.freeradbiomed.2011.09.007.
28. Zuo, A. R., Yu, Y. Y., Shu, Q. L., Zheng, L. X., Wang, X. M., et al. (2014) Hepatoprotective effects and antioxidant, antityrosinase activities of phloretin and phloretin isonicotinyl hydrazone. J. Chin. Med. Assoc. 77, 290-301. doi: 10.1016/j.jcma.2014.01.007.
29. Rezk, B. M., Haenen, G. R., van der Vijgh, W. J., and Bast, A. (2002) The antioxidant activity of phloretin: the disclosure of a new antioxidant pharmacophore in flavonoids. Biochem. Biophys. Res. Commun. 295, 9-13.
30. Bors, W., Heller, W., Michel, C., and Saran, M. (1990) Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 186, 343-355.
31. Leu, S. J., Lin, Y. P., Lin, R. D., Wen, C. L., Cheng, K. T., et al. (2006) Phenolic constituents of Malus doumeri var. formosana in the field of skin care. Biol. Pharm. Bull. 29, 740-745. doi: 10.1248/bpb.29.740.
32. Nakamura, Y., Watanabe, S., Miyake, N., Kohno, H., and Osawa, T. (2003) Dihydrochalcones: evaluation as novel radical scavenging antioxidants. J. Agric. Food Chem. 51, 3309-3312. 10.1021/jf0341060.
33. Galati, G., Sabzevari, O., Wilson, J. X., and O'Brien, P. J. (2002) Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 177, 91-104. doi: 10.1016/S0300-483X(02)00198-1.
34. Nemeikaite-Ceniene, A., Imbrasaite, A., Sergediene, E., and Cenas, N. (2005) Quantitative structure-activity relationships in prooxidant cytotoxicity of polyphenols: role of potential of phenoxyl radical/phenol redox couple. Arch. Biochem. Biophys. 441, 182-190. doi: 10.1016/j.abb.2005.07.002.
35. Babich, H., Gottesman, R. T., Liebling, E. J., and Schuck, A. G. (2008) Theaflavin-3-gallate and theaflavin-3′-gallate, polyphenols in black tea with prooxidant properties. Basic Clin. Pharmacol. Toxicol. 103, 66-74. doi: 10.1111/j.1742-7843.2008.00232.x.
36. Bouayed, J. and Bohn, T. (2010) Exogenous antioxidants - double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell. Longev. 3, 228-237. doi: 10.4161/oxim.3.4.12858.
37. Khan, H. Y., Zubair, H., Ullah, M. F., Ahmad, A., and Hadi, S. M. (2012) A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Curr. Drug Targets 13, 1738-1749. doi: 10.2174/138945012804545560.
38. Al-Sawaf, O., Clarner, T., Fragoulis, A., Kan, Y. W., Pufe, T., et al. (2015) Nrf2 in health and disease: current and future clinical implications. Clin. Sci. 129, 989-999. doi: 10.1042/CS20150436.
39. Bhakkiyalakshmi, E., Sireesh, D., Rajaguru, P., Paulmurugan, R., and Ramkumar, K. M. (2015) The emerging role of redox-sensitive Nrf2-Keap1 pathway in diabetes. Pharmacol. Res. 91, 104-114. doi: 10.1016/j.phrs.2014.10.004.
40. Lu, S. C. (2013) Glutathione synthesis. Biochim. Biophys. Acta 1830, 3143-3153. doi: 10.1016/j.bbagen.2012.09.008.
41. Kang, K. W., Ryu, J. H., and Kim, S. G. (2000) The essential role of phosphatidylinositol 3-kinase and of p38 mitogen-activated protein kinase activation in the antioxidant response element-mediated rGSTA2 induction by decreased glutathione in H4IIE hepatoma cells. Mol. Pharmacol. 58, 1017-1025. doi: 10.1124/mol.58.5.1017.
42. Itoh, K., Tong, K. I., and Yamamoto, M. (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 36, 1208-1213. doi: 10.1016/j.freeradbiomed.2004.02.075.
43. de Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J., Drukarch, B., et al. (2008) Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic. Biol. Med. 45, 1375-1383. doi: 10.1016/j.freeradbiomed.2008.09.001.
44. Noguchi, M., Yoshida, T., and Kikuchi, G. (1979) Specific requirement of NADPH-cytochrome c reductase for the microsomal heme oxygenase reaction yielding biliverdin IX alpha. FEBS Lett. 98, 281-284. doi: 10.1016/0014-5793(79)80200-8.
45. Ryter, S. W., Alam, J., and Choi, A. M. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650. doi: 10.1152/physrev.00011.2005.
46. Fujita, K., Yamafuji, M., Nakabeppu, Y., and Noda, M. (2012) Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes. Oxid. Med. Cell Longev. 2012, 324256. doi: 10.1155/2012/324256.
47. Parfenova, H., Leffler, C. W., Basuroy, S., Liu, J., and Fedinec, A. L. (2012) Antioxidant roles of heme oxygenase, carbon monoxide, and bilirubin in cerebral circulation during seizures. J. Cereb. Blood Flow Metab. 32, 1024-1034. doi: 10.1038/jcbfm.2012.13.
48. Zahir, F., Rabbani, G., Khan, R. H., Rizvi, S. J., Jamal, M. S., et al. (2015) The pharmacological features of bilirubin: the question of the century. Cell. Mol. Biol. Lett. 20, 418-447. doi: 10.1515/cmble-2015-0012.
49. Chang, M., Xue, J., Sharma, V., and Habtezion, A. (2015) Protective role of hemeoxygenase-1 in gastrointestinal diseases. Cell. Mol. Life Sci. 72, 1161-1173. doi: 10.1007/s00018-014-1790-1.
50. Aldini, G., Orioli, M., and Carini, M. (2011) Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. Mol. Nutr. Food Res. 55, 1301-1319. doi: 10.1002/mnfr.201100182.
51. Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., et al. (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA 95, 4882-4887.
52. Moghe, A., Ghare, S., Lamoreau, B., Mohammad, M., Barve, S., et al. (2015) Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol. Sci. 143, 242-255. doi: 10.1093/toxsci/kfu233.
53. Zhang, X., Hu, S., Chen, F., and Wang, M. (2014) Treatment of proteins with dietary polyphenols lowers the formation of AGEs and AGE-induced toxicity. Food Funct. 5, 2656-2661. doi: 10.1039/c4fo00244j.
54. Ma, J., Peng, X., Zhang, X., Chen, F., and Wang, M. (2011) Dual effects of phloretin and phloridzin on the glycation induced by methylglyoxal in model systems. Chem. Res. Toxicol. 24, 1304-1311. doi: 10.1021/tx2001916.
55. Sang, S., Shao, X., Bai, N., Lo, C. Y., Yang, C. S., et al. (2007) Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species. Chem. Res. Toxicol. 20, 1862-1870. doi: 10.1021/tx700190s.
56. Shao, X., Bai, N., He, K., Ho, C. T., Yang, C. S., et al. (2008) Apple polyphenols, phloretin and phloridzin: new trapping agents of reactive dicarbonyl species. Chem. Res. Toxicol. 21, 2042-2050. doi: 10.1021/tx800227v
57. Dang, T. N., Arseneault, M., Murthy, V., and Ramassamy, C. (2010) Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr. Mol. Pharmacol. 3, 66-78. doi: 10.2174/1874467211003020066.
58. Igarashi, K. and Kashiwagi, K. (2011) Protein-conjugated acrolein as a biochemical marker of brain infarction. Mol. Nutr. Food Res. 55, 1332-1341. doi: 10.1002/mnfr.201100068.
59. Anderson, E. J., Katunga, L. A., and Willis, M. S. (2012) Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clin. Exp. Pharmacol. Physiol. 39, 179-193. doi: 10.1111/j.1440-1681.2011.05641.x.
60. Pegg, A. E. (2013) Toxicity of polyamines and their metabolic products. Chem. Res. Toxicol. 26, 1782-1800. doi: 10.1021/tx400316s.
61. Yadav, U. C. and Ramana, K. V. (2013) Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid. Med. Cell. Longev. 2013, 690545. doi: 10.1155/2013/690545.
62. Marsche, G., Heller, R., Fauler, G., Kovacevic, A., Nuszkowski, A., et al. (2004) 2chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. Arterioscler. Thromb. Vasc. Biol. 24, 2302-2306. doi: 10.1161/01.ATV.0000148703.43429.25.
63. Thukkani, A. K., Hsu, F. F., Crowley, J. R., Wysolmerski, R. B., Albert, C. J., et al. (2002) Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal. J. Biol. Chem. 277, 3842-3849.
64. Thukkani, A. K., Albert, C. J., Wildsmith, K. R., Messner, M. C., Martinson, B. D., et al. (2003) Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein. J. Biol. Chem. 278, 36365-36372.
65. Thukkani, A. K., McHowat, J., Hsu, F. F., Brennan, M. L., Hazen, S. L., et al. (2003) A. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108, 3128-3133. doi: 10.1161/01.CIR.0000104564.01539.6A.
66. Thukkani, A. K., Martinson, B. D., Albert, C. J., Vogler, G. A., and Ford, D. (2005) A. Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury. Am. J. Physiol. Heart Circ. Physiol. 288, H2955-H2964. doi: 10.1152/ajpheart.00834.2004.
67. Ullen, A., Fauler, G., Köfeler, H., Waltl, S., Nusshold, C., et al. (2010) Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo. Free Radic. Biol. Med. 49, 1655-1665. doi: 10.1016/j.freeradbiomed.2010.08.025.
68. Santos, A. R., Comprido, D., and Duarte, C. B. (2010) Regulation of local translation at the synapse by BDNF. Prog. Neurobiol. 92, 505-516. doi: 10.1016/j.pneurobio.2010.08.004.
69. Leal, G., Comprido, D., and Duarte, C. B. (2014) BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology 76, 639-656. doi: 10.1016/j.neuropharm.2013.04.005.
70. Jahn, H. M., Scheller, A., and Kirchhoff, F. (2015) Genetic control of astrocyte function in neural circuits. Front. Cell. Neurosci. 9, 310. doi: 10.3389/fncel.2015.00310.
71. Yang, Z. and Wang, K. K. (2015) Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 38, 364-374. doi: 10.1016/j.tins.2015.04.003.
72. Panja, D. and Bramham, C. R. (2014) BDNF mechanisms in late LTP formation: a synthesis and breakdown. Neuropharmacology 76, 664-676. doi: 10.1016/j.neuropharm.2013.06.024.
73. Cai, S., Huang, S., and Hao, W. (2015) New hypothesis and treatment targets of depression: an integrated view of key findings. Neurosci. Bull. 31, 61-74. doi: 10.1007/s12264-014-1486-4.
74. Hertel, C., Terzi, E., Hauser, N., Jakob-Rotne, R., Seelig, J., et al. (1997) Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc. Natl. Acad. Sci. USA 94, 9412-9416.
75. Terzi, E., Hölzemann, G., and Seelig, J. (1995) Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633-642. doi: 10.1006/jmbi.1995.0525.
76. Seelig, J., Lehrmann, R., and Terzi, E. (1995) Domain formation induced by lipid-ion and lipid-peptide interactions. Mol. Membr. Biol. 12, 51-57.
77. McLaurin, J. and Chakrabartty, A. (1997) Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245, 355-363. doi: 10.1111/j.1432-1033.1997.t01-2-00355.x.
78. Butterfield, D. A. (2004) Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res. 1000, 1-7. doi: 10.1016/j.brainres.2003.12.012.
79. Swomley, A. M., Förster, S., Keeney, J. T., Triplett, J., Zhang, Z., Sultana, R., and Butterfield, D. A. (2014) Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim. Biophys. Acta 1842, 1248-1257. doi: 10.1016/j.bbadis.2013.09.015.
80. Moneim, A. E. (2015) Oxidant/antioxidant imbalance and the risk of Alzheimer's disease. Curr. Alzheimer Res. 12, 335-349. doi: 10.2174/1567205012666150325182702.
81. Bechinger, B. and Seelig, J. (1991) Interaction of electric dipoles with phospholipid head groups. A 2H and 31P NMR study of phloretin and phloretin analogues in phosphatidylcholine membranes. Biochemistry 30, 3923-3929.
82. Jo, E. and Boggs, J. M. (1994) A transmembrane potential does not affect the vertical location of charged lipid spin labels with respect to the surface of a phosphatidylcholine bilayer. Biochim. Biophys. Acta 1195, 245-251.
83. Deuticke, B., Lütkemeier, P., and Poser, B. (1991) Influence of phloretin and alcohols on barrier defects in the erythrocyte membrane caused by oxidative injury and electroporation. Biochim. Biophys. Acta 1067, 111-122. doi: 10.1016/0005-2736(91)90032-4.
84. Nishiguchi, S., Kuroki, T., Takeda, T., Nakajima, S., Shiomi, S., et al. (1990) Effects of putrescine on D-galactosamine-induced acute liver failure in rats. Hepatology 12, 348-353.
85. Li, L. J., Wu, Z. W., Xiao, D. S., and Sheng, J. F. (2004) Changes of gut flora and endotoxin in rats with D-galactosamine-induced acute liver failure. World J. Gastroenterol. 10, 2087-2090. doi: 10.3748/wjg.v10.i14.2087.
86. Chaston, T. B., Watts, R. N., Yuan, J., and Richardson, D. (2004) R. Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation. Clin. Cancer Res. 10, 7365-7374. doi: 10.1158/1078-0432.CCR-04-0865.
87. Kajal, A., Bala, S., Sharma, N., Kamboj, S., and Saini, V. (2014) Therapeutic potential of hydrazones as anti-inflammatory agents. Int. J. Med. Chem. 2014, 761030. doi: 10.1155/2014/761030.
88. Verma, G., Marella, A., Shaquiquzzaman, M., Akhtar, M., Ali, M. R., et al. (2014) A review exploring biological activities of hydrazones. J. Pharm. Bioallied. Sci. 6, 69-80. doi: 10.4103/0975-7406.129170.
89. Schaefer, S., Baum, M., Eisenbrand, G., Dietrich, H., Will, F., et al. (2006) Polyphenolic apple juice extracts and their major constituents reduce oxidative damage in human colon cell lines. Mol. Nutr. Food Res. 50, 24-33. doi: 10.1002/mnfr.200500136.
90. Vineetha, V. P., Soumya, R. S., and Raghu, K. G. (2015) Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes. Eur. J. Pharmacol. 754, 162-172. doi: 10.1016/j.ejphar.2015.02.036.
91. Sanner, J. H. (1974) Substances that inhibit the actions of prostaglandins. Arch. Intern. Med. 133, 133-146. doi: 10.1001/archinte.1974.00320130135011.
92. Blazsó, G. and Gábor, M. (1995) Effects of prostaglandin antagonist phloretin derivatives on mouse ear edema induced with different skin irritants. Prostaglandins 50, 161-168.
93. Molnar, V. and Garai, J. (2005) Plant-derived anti-inflammatory compounds affect MIF tautomerase activity. Int. Immunopharmacol. 5, 849-856. doi: 10.1016/j.intimp.2004.12.017.
94. Mikulowska, A., Metz, C. N., Bucala, R., and Holmdahl, R. (1997) Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J. Immunol. 158, 5514-5517.
95. Leech, M., Metz, C., Santos, L., Peng, T., Holdsworth, S. R., et al. (1998) Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum. 41, 910-917.
96. Leech, M., Metz, C., Hall, P., Hutchinson, P., Gianis, K., et al. (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum. 42, 1601-1608.
97. Kasama, T., Ohtsuka, K., Sato, M., Takahashi, R., Wakabayashi, K., et al. (2010) Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases. Arthritis 2010, 106202. doi: 10.1155/2010/106202.
98. Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., et al. (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341-346. doi: 10.1084/jem.189.2.341.
99. Bernhagen, J., Bacher, M., Calandra, T., Metz, C. N., Doty, S. B., et al. (1996) An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J. Exp. Med. 183, 277-282.
100. Grieb, G., Kim, B. S., Simons, D., Bernhagen, J., and Pallua, N. (2014) MIF and CD74 - suitability as clinical biomarkers. Mini Rev. Med. Chem. 14, 1125-1131. doi: 10.2174/1389557515666150203143317.
101. Xue, H., Yang, Y., Zhang, Y., Song, S., Zhang, L., et al. (2015) Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis. Mediators Inflamm. 2015, 621072. doi: 10.1155/2015/621072.
102. Lee, J. H., Regmi, S. C., Kim, J. A., Cho, M. H., Yun, H., et al. (2011) Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect. Immun. 79, 4819-4827. doi: 10.1128/IAI.05580-11.
103. Jung, M., Triebel, S., Anke, T., Richling, E., and Erkel, G. (2009) Influence of apple polyphenols on inflammatory gene expression. Mol. Nutr. Food Res. 53, 1263-1280. doi: 10.1002/mnfr.200800575.
104. Audi, S. H., Bongard, R. D., Krenz, G. S., Rickaby, D. A., Haworth, S. T., et al. (2005) Effect of chronic hyperoxic exposure on duroquinone reduction in adult rat lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L788-L797. doi: 10.1152/ajplung.00064.2005.
105. Van Raemdonck, K., Van den Steen, P. E., Liekens, S., Van Damme, J., and Struyf, S. (2015) CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev. 26, 311-273. doi: 10.1016/j.cytogfr.2014.11.009.
106. Miotto, D., Christodoulopoulos, P., Olivenstein, R., Taha, R., Cameron, L., et al. (2001) Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1; 3; and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J. Allergy Clin. Immunol. 107, 664-670. doi: 10.1067/mai.2001.113524.
107. Saetta, M., Mariani, M., Panina-Bordignon, P., Turato, G., Buonsanti, C., et al. (2002) Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165, 1404-1409.
108. Yeruva, S., Ramadori, G., and Raddatz, D. (2008) NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int. J. Colorectal Dis. 23, 305-317. doi: 10.1007/s00384-007-0396-6.
109. Brenner, D., Blaser, H., and Mak, T. W. (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15, 362-374. doi: 10.1038/nri3834.
110. Gambhir, S., Vyas, D., Hollis, M., Aekka, A., and Vyas, A. (2015) Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies. World J. Gastroenterol. 21, 3174-3183. doi: 10.3748/wjg.v21.i11.3174.
111. Zhang, F. and Jiang, L. (2015) Neuroinflammation in Alzheimer's disease. Neuropsychiatr. Dis. Treat. 11, 243-562. doi: 10.2147/NDT.S75546.
112. Cheng, J. and Fan, X. M. (2013) Role of cyclooxygenase-2 in gastric cancer development and progression. World J. Gastroenterol. 19, 7361-7368. doi: 10.3748/wjg.v19.i42.7361.
113. Cox, D. G., Crusius, J. B., Peeters, P. H., Bueno-de-Mesquita, H. B., Pena, A. S., et al. (2005) Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease. World J. Gastroenterol. 11, 6003-6008. doi: 10.3748/wjg.v11.i38.6003.
114. Chang, W. T., Huang, W. C., and Liou, C. J. (2012) Evaluation of the anti-inflammatory effects of phloretin and phlorizin in lipopolysaccharide-stimulated mouse macrophages. Food Chem. 134, 972-979. doi: 10.1016/j.foodchem.2012.03.002.
115. Hoesel, B. and Schmid, J. A. (2013) The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 12, 86. doi: 10.1186/1476-4598-12-86.
116. Radi, R. (2013) Peroxynitrite; a stealthy biological oxidant. J. Biol. Chem. 288, 26464-26472. doi: 10.1074/jbc.R113.472936.
117. Prolo, C., Alvarez, M. N., and Radi, R. (2014) Peroxynitrite; a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens. Biofactors 40, 215-225. doi: 10.1002/biof.1150.
118. Decréau, R. A. and Collman, J. P. (2015) Three toxic gases meet in the mitochondria. Front. Physiol. 6, 210. doi: 10.3389/fphys.2015.00210.
119. Mikhed, Y., Daiber, A., and Steven, S. (2015) Mitochondrial oxidative stress; mitochondrial DNA damage and their role in age-related vascular dysfunction. Int. J. Mol. Sci. 16, 15918-15953. doi: 10.3390/ijms160715918.
120. Viau, D. M., Sala-Mercado, J. A., Spranger, M. D., O'Leary, D. S., and Levy, P. D. (2015) The pathophysiology of hypertensive acute heart failure. Heart. 101, 1861-1867. doi: 10.1136/heartjnl-2015-307461.
121. Francisco, B. M., Salvador, M., and Amparo, N. (2015) Oxidative stress in myopia. Oxid. Med. Cell. Longev. 2015, 750637. doi: 10.1155/2015/750637.
122. Pisoschi, A. M. and Pop, A. (2015) The role of antioxidants in the chemistry of oxidative stress: A review. Eur. J. Med. Chem. 97, 55-74. doi: 10.1016/j.ejmech.2015.04.040.
123. Sekhon-Loodu, S. and Ziaullah Rupasinghe, H. P. (2015) Docosahexaenoic acid ester of phloridzin inhibits lipopolysaccharide-induced inflammation in THP-1 differentiated macrophages. Int. Immunopharmacol. 25, 199-206. doi: 10.1016/j.intimp.2015.01.019.
124. Lin, C. C., Chu, C. L., Ng, C. S., Lin, C. Y., Chen, D. Y., et al. (2014) Immunomodulation of phloretin by impairing dendritic cell activation and function. Food Funct. 5, 997-1006. doi: 10.1039/c3fo60548e.
125. Manček-Keber, M. and Jerala, R. (2015) Postulates for validating TLR4 agonists. Eur. J. Immunol. 45, 356-370. doi: 10.1002/eji.201444462.
126. Galkina, E. and Ley, K. (2009) Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 27, 165-197. doi: 10.1146/annurev.immunol.021908.132620.
127. Oyoshi, M. K., He, R., Kumar, L., Yoon, J., and Geha, R. S. (2009) Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol. 102, 135-226. doi: 10.1016/S0065-2776(09)01203-6.
128. Fordham, J. B., Naqvi, A. R., and Nares, S. (2014) Leukocyte production of inflammatory mediators is inhibited by the antioxidants phloretin; silymarin; hesperetin; and resveratrol. Mediators Inflamm. 2014, 938712 doi: 10.1155/2014/938712.
129. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and de Vries, J. E. (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
130. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822.
131. Huang, W. C., Chang, W. T., Wu, S. J., Xu, P. Y., Ting, N. C., et al. (2013) Phloretin and phlorizin promote lipolysis and inhibit inflammation in mouse 3T3-L1 cells and in macrophage-adipocyte co-cultures. Mol. Nutr. Food Res. 57, 1803-1813. doi: 10.1002/mnfr.201300001.
132. Huang, W. C., Dai, Y. W., Peng, H. L., Kang, C. W., Kuo, C. Y., et al. (2015) Phloretin ameliorates chemokines and ICAM-1 expression via blocking of the NF-κB pathway in the TNF-α-induced HaCaT human keratinocytes. Int. Immunopharmacol. 27, 32-37. doi: 10.1016/j.intimp.2015.04.024.
133. Youn, G. S., Kwon, D. J., Ju, S. M., Choi, S. Y., and Park, J. (2013) Curcumin ameliorates TNF-α-induced ICAM-1 expression and subsequent THP-1 adhesiveness via the induction of heme oxygenase-1 in the HaCaT cells. BMB Rep. 46, 410-415. doi: 10.5483/BMBRep.2013.46.8.014.
134. Yarbrough, K. B., Neuhaus, K. J., and Simpson, E. L. (2013) The effects of treatment on itch in atopic dermatitis. Dermatol. Ther. 26, 110-119. doi: 10.1111/dth.12032.
135. Milani, P., Ambrosi, G., Gammoh, O., Blandini, F., and Cereda, C. (2013) SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration. Oxid. Med. Cell Longev. 2013, 836760 doi: 10.1155/2013/836760.
136. Lim, J. L., Wilhelmus, M. M., de Vries, H. E., Drukarch, B., Hoozemans, J. J., et al. (2014) Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Arch. Toxicol. 88, 1773-1786. doi: 10.1007/s00204-014-1338-z.
137. Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S., and Yoshida, T. (2003) Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell. Physiol. 285, C334-C342. doi: 10.1152/ajpcell.00043.2003.
138. Huang, W. C., Wu, S. J., Tu, R. S., Lai, Y. R., and Liou, C. J. (2015) Phloretin inhibits interleukin-1β-induced COX-2 and ICAM-1 expression through inhibition of MAPK; Akt; and NF-κB signaling in human lung epithelial cells. Food Funct. 6, 1960-1967. doi: 10.1039/c5fo00149h.
139. Kumar, S., Verma, A. K., Das, M., and Dwivedi, P. D. (2012) Molecular mechanisms of IgE mediated food allergy. Int. Immunopharmacol. 13, 432-439. doi: 10.1016/j.intimp.2012.05.018.
140. Zhu, S. P., Liu, G., Wu, X. T., Chen, F. X., Liu, J. Q., et al. (2013) The effect of phloretin on human γδ T cells killing colon cancer SW-1116 cells. Int. Immunopharmacol. 15, 6-14. doi: 10.1016/j.intimp.2012.11.001.
141. Wu, C. H., Ho, Y. S., Tsai, C. Y., Wang, Y. J., Tseng, H., et al. (2009) In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter. Int. J. Cancer 124, 2210-2219. doi: 10.1002/ijc.24189.
142. Yang, K. C., Tsai, C. Y., Wang, Y. J., Wei, P. L., Lee, C. H., et al. (2009) Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. Mol. Carcinog. 48, 420-431. doi: 10.1002/mc.20480.
143. Kim, M. S., Kwon, J. Y., Kang, N. J., Lee, K. W., and Lee, H. J. (2009) Phloretin induces apoptosis in H-Ras MCF10A human breast tumor cells through the activation of p53 via JNK and p38 mitogen-activated protein kinase signaling. Ann. N. Y. Acad. Sci. 1171, 479-483. doi: 10.1111/j.1749-6632.2009.04692.x.
144. Nair, S. V. and Ziaullah Rupasinghe, H. P. (2014) Fatty acid esters of phloridzin induce apoptosis of human liver cancer cells through altered gene expression. PLoS One 9, e107149. doi: 10.1371/journal.pone.0107149.
145. Shin, J. W., Kundu, J. K., and Surh, Y. J. (2012) Phloretin inhibits phorbol ester-induced tumor promotion and expression of cyclooxygenase-2 in mouse skin: extracellular signal-regulated kinase and nuclear factor-κB as potential targets. J. Med. Food 15, 253-257. doi: 10.1089/jmf.2011.1851.
146. Nusse, R. and Varmus, H. E. (1992) Wnt genes. Cell 69, 1073-1087.
147. Campillo, J. A., Martínez-Escribano, J. A., Minguela, A., López-Alvarez, R., Marín, L. A., et al. (2007) Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma. Dermatology 214, 283-288.
148. Bjorklund, C. C., Ma, W., Wang, Z. Q., Davis, R. E., Kuhn, D. J., et al. (2011) Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide. J. Biol. Chem. 286, 11009-11020. doi: 10.1074/jbc.M110.180208.
149. Alter, G., Malenfant, J. M., and Altfeld, M. (2004) CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294, 15-22. doi: 10.1016/j.jim.2004.08.008.
150. Uchida, R., Ashihara, E., Sato, K., Kimura, S., Kuroda, J., et al. (2007) Gamma delta T cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface. Biochem. Biophys. Res. Commun. 354, 613-618. doi: 10.1016/j.bbrc.2007.01.031.
151. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917. doi: 10.1002/ijc.25516.
152. Cao, X., Fang, L., Gibbs, S., Huang, Y., Dai, Z., et al. (2007) Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother. Pharmacol. 59, 495-505. doi: 10.1007/s00280-006-0291-9.
153. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314.
154. Gatenby, R. A. (1995) The potential role of transformation-induced metabolic changes in tumor-host interaction. Cancer Res. 55, 4151-4156.
155. Seagroves, T. N., Ryan, H. E., Lu, H., Wouters, B. G., Knapp, M., et al. (2001) Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21, 3436-3444. doi: 10.1128/MCB.21.10.3436-3444.2001.
156. Gonzalez-Menendez, P., Hevia, D., Rodriguez-Garcia, A., Mayo, J. C., and Sainz, R. M. (2014) Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells. Endocrinology 155, 3238-3250. doi: 10.1210/en.2014-1260.
157. Kobori, M., Shinmoto, H., Tsushida, T., and Shinohara, K. (1997) Phloretin-induced apoptosis in B16 melanoma 4A5 cells by inhibition of glucose transmembrane transport. Cancer Lett. 119, 207-212.
158. Kobori, M., Iwashita, K., Shinmoto, H., and Tsushida, T. (1999) Phloretin-induced apoptosis in B16 melanoma 4A5 cells and HL60 human leukemia cells. Biosci. Biotechnol. Biochem. 63, 719-725.
159. Hiraoka, A., Ochi, M., Matsuda, R., Aibiki, T., Okudaira, T., et al. (2015) Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus. J. Diabetes. doi: 10.1111/1753-0407.12340.
160. Niwa, Y., Ishikawa, K., Ishigami, M., Honda, T., Achiwa, K., et al. (2015) Effect of hyperglycemia on hepatocellular carcinoma development in diabetes. Biochem. Biophys. Res. Commun. 463, 344-350. doi: 10.1016/j.bbrc.2015.05.066.
161. Park, S. Y., Kim, E. J., Shin, H. K., Kwon, D. Y., Kim, M. S., et al. (2007) Induction of apoptosis in HT-29 colon cancer cells by phloretin. J. Med. Food 10, 581-586. 10.1089/jmf.2007.116.
162. Cao, Q. J., Einstein, M. H., Anderson, P. S., Runowicz, C. D., Balan, R., et al. (2002) Expression of COX-2; Ki-67; cyclin D1; and P21 in endometrial endometrioid carcinomas. Int. J. Gynecol. Pathol. 21, 147-154.
163. Mohan, S. and Epstein, J. B. (2003) Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol. 39, 537-546.
164. Surh, Y. J. and Kundu, J. K. (2005) Signal transduction network leading to COX-2 induction: a road map in search of cancer chemopreventives. Arch. Pharm. Res. 28, 1-15.
165. Shin, S., Kum, H., Ryu, D., Kim, M., Jung, E., et al. (2014) Protective effects of a new phloretin derivative against UVB-induced damage in skin cell model and human volunteers. Int. J. Mol. Sci. 15, 18919-18940. doi: 10.3390/ijms151018919.
166. Wang, X., Takahashi, N., Uramoto, H., and Okada, Y. (2005) Chloride channel inhibition prevents ROS-dependent apoptosis induced by ischemia-reperfusion in mouse cardiomyocytes. Cell Physiol. Biochem. 16, 147-154. doi: 10.1159/000089840.
167. Shimizu, T., Numata, T., and Okada, Y. (2004) A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl(-) channel. Proc. Natl. Acad. Sci. USA 101, 6770-6773. doi: 10.1073/pnas.0401604101.
168. San Miguel, S. M., Opperman, L. A., Allen, E. P., Zielinski, J., and Svoboda, K. K. (2012) Bioactive polyphenol antioxidants protect oral fibroblasts from ROS-inducing agents. Arch. Oral Biol. 57, 1657-1667. doi: 10.1016/j.archoralbio.2012.04.021.
169. San Miguel, S. M., Opperman, L. A., Allen, E. P., Zielinski, J., and Svoboda, K. K. (2010) Antioxidants counteract nicotine and promote migration via RacGTP in oral fibroblast cells. J. Periodontol. 81, 1675-1690. doi: 10.1902/jop.2010.100187.
170. San Miguel, S. M., Opperman, L. A., Allen, E. P., Zielinski, J., and Svoboda, K. K. (2011) Bioactive antioxidant mixtures promote proliferation and migration on human oral fibroblasts. Arch. Oral Biol. 56, 812-822. doi: 10.1016/j.archoralbio.2011.01.001.
171. Hassan, M., El Yazidi, C., Landrier, J. F., Lairon, D., Margotat, A., et al. (2007) Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells. Biochem. Biophys. Res. Commun. 361, 208-213. doi: 10.1016/j.bbrc.2007.07.021.
172. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., et al. (2006) Adiponectin and adiponectin receptors in insulin resistance; diabetes; and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792. doi: 10.1172/JCI29126.
173. Fu, Y., Luo, N., Klein, R. L., and Garvey, W. T. (2005) Adiponectin promotes adipocyte differentiation; insulin sensitivity; and lipid accumulation. J. Lipid Res. 46, 1369-1379. doi: 10.1194/jlr.M400373-JLR200.
174. Farmer, S. R. (2006) Transcriptional control of adipocyte formation. Cell Metab. 4, 263-273. doi: 10.1016/j.cmet.2006.07.001.
175. Shu, G., Lu, N. S., Zhu, X. T., Xu, Y., Du, M. Q., et al. (2014) Phloretin promotes adipocyte differentiation in vitro and improves glucose homeostasis in vivo. J. Nutr. Biochem. 25, 1296-1308. doi: 10.1016/j.jnutbio.2014.07.007.
176. Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Mohideen, P., Carter, L., et al. (2000) Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49, 263-271.
177. Ross, S. E., Erickson, R. L., Hemati, N., and MacDougald, O. A. (1999) Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol. Cell. Biol. 19, 8433-8441.
178. Camp, H. S. and Tafuri, S. R. (1997) Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 10811-10816.
179. Hu, E., Kim, J. B., Sarraf, P., and Spiegelman, B. M. (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274, 2100-2103.
180. Hassan, M., El Yazidi, C., Malezet-Desmoulins, C., Amiot, M. J., and Margotat, A. (2010) Gene expression profiling of 3T3-L1 adipocytes exposed to phloretin. J. Nutr. Biochem. 21, 645-652. doi: 10.1016/j.jnutbio.2009.04.006.
181. Maeda, N., Hibuse, T., and Funahashi, T. (2009) Role of aquaporin-7 and aquaporin-9 in glycerol metabolism; involvement in obesity. Handb. Exp. Pharmacol. 190, 233-249. doi: 10.1007/978-3-540-79885-9_12.
182. Maruthur, N. M., Gudzune, K., Hutfless, S., Fawole, O. A., Wilson, R. F., et al. (2014) Avoiding weight gain in cardiometabolic disease: a systematic review. J. Obes. 2014, 358919 doi: 10.1155/2014/358919.
183. Andersen, J. R., Aasprang, A., Karlsen, T. I., Natvig, G. K., Våge, V., et al. (2015) Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. Surg. Obes. Relat. Dis. 11, 466-473. doi: 10.1016/j.soard.2014.10.027.
184. Lee, E. J., Kim, J. L., Kim, Y. H., Kang, M. K., Gong, J. H., et al. (2014) Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice. Phytomedicine 21, 1208-1215. doi: 10.1016/j.phymed.2014.04.002.
185. Nagai, H., Noguchi, T., Takeda, K., and Ichijo, H. (2007) Pathophysiological roles of ASK1-MAP kinase signaling pathways. J. Biochem. Mol. Biol. 40, 1-6.
186. Shiizaki, S., Naguro, I., and Ichijo, H. (2013) Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling. Adv. Biol. Regul. 53, 135-144. doi: 10.1016/j.jbior.2012.09.006.
187. Feng, X. (2005) RANKing intracellular signaling in osteoclasts. IUBMB Life 57, 389-395. doi: 10.1080/15216540500137669.
188. Kim, J. L., Kang, M. K., Gong, J. H., Park, S. H., Han, S. Y., et al. (2012) Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages. Mol. Nutr. Food Res. 56, 1223-1233. doi: 10.1002/mnfr.201100831.
189. Parikka, V., Lehenkari, P., Sassi, M. L., Halleen, J., Risteli, J., et al. (2001) Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology 142, 5371-5378.
190. Nakamura, I., Duong, L. T., Rodan, S. B., and Rodan, G. A. (2007) Involvement of alpha(v)beta3 integrins in osteoclast function. J. Bone Miner. Metab. 25, 337-344. doi: 10.1007/s00774-007-0773-9.
191. Blair, H. C. and Zaidi, M. (2006) Osteoclastic differentiation and function regulated by old and new pathways. Rev. Endocr. Metab. Disord. 7, 23-32. doi: 10.1007/s11154-006-9010-4.
192. Yuan, F. L., Li, X., Lu, W. G., Li, C. W., Li, J. P., et al. (2010) The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis. Mol. Biol. Rep. 37, 3561-3566. doi: 10.1007/s11033-010-0004-7.
193. Asagiri, M. and Takayanagi, H. (2007) The molecular understanding of osteoclast differentiation. Bone 40, 251-264. doi: 10.1016/j.bone.2006.09.023.
194. Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342. doi:10.1038/nature01658.
195. Sabzevari, O., Galati, G., Moridani, M. Y., Siraki, A., and O'Brien, P. J. (2004) Molecular cytotoxic mechanisms of anticancer hydroxychalcones. Chem. Biol. Interact. 148, 57-67. doi:10.1016/j.cbi.2004.04.004.
196. Moridani, M. Y., Galati, G., and O'Brien, P. J. (2002) Comparative quantitative structure toxicity relationships for flavonoids evaluated in isolated rat hepatocytes and HeLa tumor cells. Chem. Biol. Interact. 139, 251-264. doi:10.1016/S0009-2797(02)00005-4.
197. Frerich, H. and Ball, E. G. (1964) Studies on the metabolism of adipose tissue. XVI. Inhibition by phloridzin and phloretin of the insulin-stimulated uptake of glucose. Biochemistry 3, 981-985.
198. 2+-mediated oxidative modification of human low density lipoproteins. Eur. J. Nutr. 44, 422-428. doi: 10.1007/s00394-005-0546-y.
199. Choi, I., Kim, J., Jeong, H. K., Kim, B., Jou, I., et al. (2013) PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction; reduced AKT and increased p38 MAPK activation; and downregulation of EGFR. Glia 61, 800-812. doi: 10.1002/glia.22475.
200. Rüb, C., Schröder, N., and Voos, W. (2015) Biochemical properties of the kinase PINK1 as sensor protein for mitochondrial damage signalling. Biochem. Soc. Trans. 43, 287-291. doi: 10.1042/BST20150005.
201. Beilina, A., Van Der Brug, M., Ahmad, R., Kesavapany, S., Miller, D. W., et al. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl. Acad. Sci. USA 102, 5703-5708. doi: 10.1073/pnas.0500617102.
202. Sim, C. H., Lio, D. S., Mok, S. S., Masters, C. L., Hill, A. F., et al. (2006) Cterminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum. Mol. Genet. 15, 3251-3262. doi: 10.1093/hmg/ddl398.
203. Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., et al. (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell 33, 627-638. doi: 10.1016/j.molcel.2009.02.013.
204. Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., et al. (2001) Localization of a novel locus for autosomal recessive early-onset parkinsonism; PARK6; on human chromosome 1p35-p36. Am. J. Hum. Genet. 68, 895-900. doi:10.1086/319522.
205. Frey, M. R., Dise, R. S., Edelblum, K. L., and Polk, D. B. (2006) p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J. 25, 5683-5692. doi: 10.1038/sj.emboj.7601457.
206. Vergarajauregui, S., San Miguel, A., and Puertollano, R. (2006) Activation of p38 mitogen-activated protein kinase promotes epidermal growth factor receptor internalization. Traffic 7, 686-698. doi: 10.1111/j.1600-0854.2006.00420.x.
207. De Jonge, P. C., Wieringa, T., Van Putten, J. P., Krans, H. M., and Van Dam, K. (1983) Phloretin - an uncoupler and an inhibitor of mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta 722, 219-225.
208. Zheng, J. and Ramirez, V. D. (2000) Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 130, 1115-1123. doi: 10.1038/sj.bjp.0703397.
209. Tomecková, V., Guzy, J., Kusnír, J., Fodor, K., Mareková, M., et al. (2006) Comparison of the effects of selected chalcones; dihydrochalcones and some cyclic flavonoids on mitochondrial outer membrane determined by fluorescence spectroscopy. J. Biochem. Biophys. Methods 69, 143-150. doi:10.1016/j.jbbm.2006.05.004.
210. Green, D. R., Galluzzi, L., and Kroemer, G. (2014) Metabolic control of cell death. Science 345, 1250256 doi: 10.1126/science.1250256.
211. Zhang, K., Yang, E. B., Tang, W. Y., Wong, K. P., and Mack, P. (1997) Inhibition of glutathione reductase by plant polyphenols. Biochem. Pharmacol. 54, 1047-1053. doi: 10.1016/S0006-2952(97)00315-8.
212. Rashid, K., Sinha, K., and Sil, P. C. (2013) An update on oxidative stress-mediated organ pathophysiology. Food Chem. Toxicol. 62, 584-600. doi: 10.1016/j.fct.2013.09.026.
213. Lu, S. C. (2009) Regulation of glutathione synthesis. Mol. Aspects Med. 30, 42-59. doi: 10.1016/j.mam.2008.05.005.
214. Kalinina, E. V., Chernov, N. N., and Novichkova, M. D. (2014) Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochemistry 79, 1562-1583. doi: 10.1134/S0006297914130082.
215. Mazzetti, A. P., Fiorile, M. C., Primavera, A., and Lo Bello, M. (2015) Glutathione transferases and neurodegenerative diseases. Neurochem. Int. 82, 10-18. doi: 10.1016/j.neuint.2015.01.008.